The Global Anti-Parkinson Drugs Market Report by The Business Research Company covers anti-Parkinson drugs market drivers and restraints, anti-Parkinson drugs market size, major players, and the impact of COVID-19 on the anti-Parkinson drugs market.
The anti-Parkinson drugs market consists of sales of drugs used for treating Parkinson’s disease (PD), generated by the establishments that manufacture these drugs. Parkinson’s disease is a neurodegenerative disorder that affects predominately dopaminergic neurons in a specific area of the brain named substantia nigra and disturbs the movement of the body. People suffering from PD may experience tremor, bradykinesia, limb rigidity, gait, and balance problems.
The increasing geriatric population and surging cases of Parkinson’s disease (PD) are projected to drive the demand for the anti-Parkinson drugs market. The global anti-Parkinson drugs market is expected to grow from $5.3 billion in 2020 to $5.55 billion in 2021 at a compound annual growth rate (CAGR) of 4.7%. The growth is mainly due to the companies rearranging their operations and recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The market is expected to reach $7.78 billion in 2025 at a CAGR of 9%.
Request A Sample For The Global Anti-Parkinson Drugs Market Report:
Some anti-Parkinson drugs market trends include investments by governments and companies for Parkinson’s disease drug R&D. For instance, according to the report published in 2018 by the Parkinson’s Foundation, the foundation awarded $6 million to Parkinson’s disease (PD) research.
Global anti-Parkinson drugs market segments include:
1) By Drugs Class: Levodopa/Carbidopa, Dopamine Receptor Agonists, Monoamine Oxidase Type B (MAO-B) Inhibitors, Catechol-O-Methyltransferase (COMT)-inhibitors, Anticholinergics, Other Drugs.
2) By Route of Administration: Oral, Injection, Transdermal.
3) By Distribution Channel: Hospital Pharmacies, Retailer Pharmacies, Online Pharmacies.
By Geography: The market is segmented into North America, South America, Asia-Pacific, Eastern Europe, Western Europe, Middle East and Africa.
Read More On The Anti-Parkinson Drugs Global Market Report 2021: COVID 19 Impact and Recovery to 2030 At:
The Anti-Parkinson Drugs Global Market Report 2021: COVID 19 Impact and Recovery to 2030 is one of a series of new reports from The Business Research Company that provides anti-Parkinson drugs market overviews, analyzes and forecasts market size, share, anti-Parkinson drugs market players, anti-Parkinson drugs market segments and geographies, market’s leading competitors’ revenues, profiles and market shares.
The anti-Parkinson drugs identifies top countries and segments for opportunities and strategies based on market trends and leading competitors’ approaches.
Where To Learn More:
Read Anti-Parkinson Drugs Global Market Report 2021: COVID 19 Impact and Recovery to 2030 from The Business Research Company for information on the following:
Data Segmentations: Market Size, Global, By Region And By Country, Historic And Forecast Size, And Growth Rates For The World, 7 Regions And 12 Countries
Market Players Covered: Please add the major players
Regions: Asia-Pacific, China, Western Europe, Eastern Europe, North America, USA, South America, Middle East and Africa.
Countries: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.
Time Series: Five years historic (2015-20) and ten years forecast (2021-2025-2030)
Other Information And Analyses: SWOT analysis, customer information, market product/service analysis – product examples, trends and opportunities, drivers and restraints, key mergers and acquisitions, suggested trend based strategies, impact of COVID-19 on the market, future outlook and potential analysis, key metrics covered: number of enterprises, number of employees, global market in 2021 – countries offering most new opportunities, conclusions and recommendations by expert analysts.
Sourcing And Referencing: Data and analysis throughout the report are sourced using end notes.
Strategies For Participants In The Anti-Parkinson Drugs Industry: The report explains a number of strategies for companies in the market, based on industry trends and company analysis.
Opportunities For Companies In The Anti-Parkinson Drugs Sector: The report reveals where the global industry will put on most $ sales up to 2023.
Interested to know more about The Business Research Company?
The business research company has published over 1000 industry reports, covering over 2500 market segments and 60 geographies. the reports draw on 150,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders. the reports are updated with a detailed analysis of the impact of covid-19 on various markets.
Read more about us at https://www.thebusinessresearchcompany.com/about-the-business-research-company.aspx
Here is a list of reports from The Business Research Company similar to the Anti-Parkinson Drugs Global Market Report 2021: